SLC1A2 and central nervous system cancer: The brain coronal sections of vehicle- and sEVs-treated glioma-bearing mice were assayed by IF for Glt-1, and as reported in Figure 4C,D, sEVs-treated mice showed an increased expression of the transporter on the RFP-positive cells compared to that on the vehicle-treated mice.